paclitaxel has been researched along with Cancer of Mouth in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (7.55) | 18.2507 |
| 2000's | 18 (33.96) | 29.6817 |
| 2010's | 18 (33.96) | 24.3611 |
| 2020's | 13 (24.53) | 2.80 |
| Authors | Studies |
|---|---|
| Agostini, M; Almeida, LY; Bastos, DC; Coletta, RD; Cuadra Zelaya, FJM; Daher, URN; Graner, E; Kowalski, LP; Mariano, FS; Moreira, FDS; Ortiz, CA; Santos, GASD | 1 |
| Kirita, T; Kurita, H; Matsumura, T; Naruse, T; Okura, M; Ota, Y; Otsuru, M; Sasaki, M; Shintani, Y; Umeda, M; Yamada, SI; Yamakawa, N; Yanamoto, S | 1 |
| Kii, T; Sakuma, K; Tanaka, A; Yoda, M | 1 |
| Han, S; Ho, PY; Jiang, N; Jing, D; Lam, KS; Li, JJ; Li, Y; Mao, C; Wang, F; Xiao, W; Zhang, L | 1 |
| Hussein, HA; Khaphi, FL | 1 |
| Dadgar, E; Esfahaniani, M; Hassani, P; Mortezagholi, B; Movahed, E; Nasiri, K; Nejati, ST; Rafieyan, S | 1 |
| Chen, Y; Dong, M; Dou, S; Huang, Y; Ju, W; Li, J; Liu, Y; Shi, W; Sun, J; Sun, Q; Tang, Y; Zhang, D; Zhao, T; Zhong, L; Zhou, X; Zhou, Z; Zhu, D; Zhu, G; Zhu, Q | 1 |
| Guo, J; Jia, R; Shao, J; Sun, Y; Yan, L | 1 |
| Chen, J; Chen, L; Fan, L; Pu, Y; Wang, J; Wang, Y; Xia, C; Zhang, Q | 1 |
| Fukumoto, C; Hasegawa, T; Hitomi-Koide, M; Hyodo, T; Kamimura, R; Kawamata, H; Komiyama, Y; Nakashiro, KI; Sawatani, Y; Shimura, M; Uchida, D | 1 |
| Dobleman, T; Hu, S; Liu, J; Xiao, GG; Xiao, KC; Yang, Q | 1 |
| de Carvalho Fraga, CA; de Souza, MG; Farias, LC; Guimarães, ALS; Guimarães, TA; Jones, KM; Xavier, GM | 1 |
| Bharadwaj, R; Medhi, S | 1 |
| Kii, T; Sakuma, K; Tanaka, A | 1 |
| Choi, JI; Kim, DJ; Kim, SJ; Lee, JH; Park, BS; Park, HR; Song, JM; Woo, BH | 1 |
| Chang, JY; Chang, KY; Chen, CC; Chiu, CF; Chu, CY; Hsieh, CY; Tsai, KY; Tsai, ST; Tsao, CJ; Tsou, HH; Yen, CJ | 1 |
| Forbes, RC; Lindsey, DE; Mansfield, SA; Papadimos, TJ; Stawicki, SP | 1 |
| Ferdous, T; Harada, K; Kobayashi, H; Ueyama, Y | 1 |
| Gao, HD; Guo, YZ; Liu, ZS; Wang, PY; Xie, Q; Xie, WL; Zhang, HF | 1 |
| Arya, S; Bhattacharjee, A; D'Cruz, A; Dhumal, S; Joshi, A; Juvekar, S; Kane, S; Muddu, V; Noronha, V; Patil, VM; Prabhash, K | 1 |
| Higo, M; Kasama, H; Kasamatsu, A; Koyama, T; Miyamoto, I; Nakashima, D; Ogawara, K; Okamoto, A; Shiiba, M; Tanzawa, H; Uzawa, K; Yokoe, H | 1 |
| Chen, Y; Fang, X; Gao, F; Huang, Y; Zhang, W | 1 |
| Borel, C; Ciftci, S; Debry, C; Dupret-Bories, A; Schmaltz, H; Schultz, P; Takeda-Raguin, C | 1 |
| Hegde, HV; Hoti, SL; Karthikeyan, S; Nazeer, Y | 1 |
| Han, HY; Jeong, SH; Kim, H; Kim, HJ; Kim, JH; Lee, HE; Ryu, MH | 1 |
| Li, JF; Liu, M; Wang, XX; Zhang, J | 1 |
| Hirota, M; Husain, SR; Kioi, M; Nakashima, H; Puri, RK; Shimamura, T; Tohnai, I | 1 |
| Brockhoff, G; Driemel, O; Ettl, T; Felthaus, O; Gosau, M; Hautmann, M; Morsczeck, C; Reck, A; Reichert, TE; Schmalz, G; Zeitler, K | 1 |
| Cha, IH; Li, S; Nam, W | 1 |
| Ahn, SG; Jeon, DI; Kim, SA; Kwon, SM; Park, JH; Yoon, HE; Yoon, JH | 1 |
| Froelich, K; Ginzkey, C; Hackenberg, S; Hagen, R; Harnisch, W; Kleinsasser, N; Koehler, C; Scherzed, A | 1 |
| Cox, J; Fritzsche, A; Gosnell, D; Graham, R; Ledwitch, K; Manning, T; Ogburn, R | 1 |
| Chen, W; Guo, W; Lin, L; Xu, Q; Zhou, X | 1 |
| Bekele, BN; Bucana, CD; Doan, DD; Fidler, IJ; Greenberg, JS; Holsinger, FC; Jasser, SA; Myers, JN; Schiff, BA; Swan, EA; Younes, MN | 1 |
| Becker, A; Bloching, M; Dunst, J; Hänsgen, G; Kuhnt, T; Lotterer, E; Passmann, M; Pelz, T; Pigorsch, S | 1 |
| Huang, GC; Kuo, YY; Lin, MH; Liu, SY; Liu, YC | 1 |
| Bekele, BN; Bucana, CD; Doan, D; Fidler, IJ; Jasser, SA; Myers, JN; Schiff, BA; Yigitbasi, OG; Younes, MN | 1 |
| Akino, K; Hiratsuka, H; Imai, K; Kashima, L; Mita, H; Nishikawa, N; Noguchi, M; Ogi, K; Sasaki, Y; Satoh, A; Shinomura, Y; Suzuki, H; Tokino, T; Toyota, M | 1 |
| Eckardt, A; Karstens, JH; Wegener, G | 1 |
| Jaglowski, JR; Stack, BC | 1 |
| Fujisawa, A; Ikeda, H; Inokuchi, T; Nonaka, M; Uehara, M | 1 |
| Agrawal, A; Grecula, JC; Ozer, E; Rhoades, CA; Schuller, DE; Young, DC | 1 |
| Seow, WY; Xue, JM; Yang, YY | 1 |
| Haraf, DJ; Helenowski, IB; Lazarus, C; Logemann, JA; Maccracken, E; Mittal, BB; Pauloski, BR; Rademaker, AW; Vokes, EE; Vonesh, EF | 1 |
| Janus, SC; Ondrey, FG; Weurtz, B | 1 |
| Bruno, A; Damascelli, B; Di Tolla, G; Frigerio, LF; Garbagnati, F; Lanocita, R; Marchianò, A; Mattavelli, F; Patelli, G; Spreafico, C; Tichá, V; Zunino, F | 1 |
| Bremer, M; Eckardt, A; Hofele, C; Reuter, C; Sinikovic, B | 1 |
| Chi, CW; Lin, HL; Liu, TY; Wu, CW | 1 |
| Eckardt, A; Fokas, K; Haindl, J; Hüttmann, C | 1 |
| Eckardt, A; Karstens, JH; Wildfang, I | 1 |
| Hong, SD; Hong, SP; Kim, MJ; Kim, YY; Myoung, H | 1 |
| Chen, X; Han, R; He, W; Kong, M; Li, J; Li, Y; Si, Y; Wu, H | 1 |
| Kovács, AF; Schiemann, M; Turowski, B | 1 |
3 review(s) available for paclitaxel and Cancer of Mouth
| Article | Year |
|---|---|
Pathways Related to the Anti-Cancer Effects of Metabolites Derived from Cerrado Biome Native Plants: An Update and Bioinformatics Analysis on Oral Squamous Cell Carcinoma.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Brazil; Carcinogenesis; Carcinoma, Squamous Cell; Cell Proliferation; Computational Biology; Etoposide; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Mouth Neoplasms; Neoplasm Proteins; Paclitaxel; Plant Extracts; Plants, Medicinal; Vinblastine | 2021 |
Acute upper gastrointestinal bleeding secondary to Kaposi sarcoma as initial presentation of HIV infection.
Topics: Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Biomarkers, Tumor; CD4 Lymphocyte Count; Endoscopy, Digestive System; Erythrocyte Transfusion; Female; Gastrointestinal Hemorrhage; HIV Infections; Humans; Immunoglobulins, Intravenous; Middle Aged; Mouth Neoplasms; Multimodal Imaging; Paclitaxel; Positron-Emission Tomography; Purpura, Thrombocytopenic, Idiopathic; Sarcoma, Kaposi; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Taxol: efficacy against oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Survival; Clinical Trials as Topic; Disease Models, Animal; Drug Therapy, Combination; Humans; Mouth Neoplasms; Paclitaxel; Platinum Compounds; Survival Rate; Tongue Neoplasms | 2013 |
7 trial(s) available for paclitaxel and Cancer of Mouth
| Article | Year |
|---|---|
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Survival Rate | 2019 |
Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Cohort Studies; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasm Metastasis; Oropharyngeal Neoplasms; Paclitaxel; Radiotherapy Dosage; Stomatitis; Survival Analysis; Time Factors | 2003 |
Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Otorhinolaryngologic Surgical Procedures; Paclitaxel; Patient Compliance; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome | 2006 |
Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Catheterization; Drug Carriers; Feasibility Studies; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Nanoparticles; Paclitaxel; Pharyngeal Neoplasms; Pilot Projects; Serum Albumin; Treatment Outcome | 2007 |
Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Preoperative Care; Prognosis; Prospective Studies; Survival Rate | 2007 |
[Simultaneous radiochemotherapy with taxol/carboplatin in advanced operable head-neck tumors. Preliminary results].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy Dosage; Treatment Outcome | 1999 |
Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Docetaxel; Dose Fractionation, Radiation; Drug Tolerance; Feasibility Studies; Female; Humans; Injections, Intra-Arterial; Lymph Node Excision; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Patient Compliance; Pilot Projects; Prognosis; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Survival Analysis; Taxoids | 2002 |
43 other study(ies) available for paclitaxel and Cancer of Mouth
| Article | Year |
|---|---|
FASN inhibition sensitizes metastatic OSCC cells to cisplatin and paclitaxel by downregulating cyclin B1.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin B1; Fatty Acid Synthase, Type I; Fatty Acid Synthases; Fluorouracil; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Orlistat; Paclitaxel; Squamous Cell Carcinoma of Head and Neck | 2023 |
Multicenter Retrospective Study of Weekly Cetuximab Plus Paclitaxel for Recurrent or Metastatic Oral Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Disease Progression; Drug Administration Schedule; Female; Humans; Japan; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Progression-Free Survival; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Time Factors | 2021 |
Study of the Acquisition of Sensitivity to Paclitaxel Plus Cetuximab by the Addition of Low-dose Proteasome Inhibitor.
Topics: Antibodies, Monoclonal, Humanized; Bortezomib; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Humans; Mouth Neoplasms; Neoplasm Recurrence, Local; NF-kappa B; Paclitaxel; Proteasome Inhibitors; RNA, Messenger | 2022 |
Nanoradiosensitizer with good tissue penetration and enhances oral cancer radiotherapeutic effect.
Topics: Cell Line, Tumor; Disulfides; Humans; Micelles; Mouth Neoplasms; Paclitaxel; Tissue Distribution | 2022 |
The Apoptotic Activity of Curcumin Against Oral Cancer Cells Without Affecting Normal Cells in Comparison to Paclitaxel Activity.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Curcumin; Humans; Mouth Neoplasms; Paclitaxel; Reactive Oxygen Species; Tongue Neoplasms | 2023 |
MiR-34 by targeting p53 induces apoptosis and DNA damage in paclitaxel-resistant human oral squamous carcinoma cells.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; DNA Damage; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Mouth Neoplasms; Paclitaxel; Tumor Suppressor Protein p53 | 2023 |
Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial).
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Neoadjuvant Therapy; Paclitaxel; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Microenvironment | 2023 |
Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
Topics: Alternative Splicing; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinogenesis; Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Mouth Neoplasms; Oligonucleotides, Antisense; Paclitaxel; Serine-Arginine Splicing Factors | 2019 |
Glutathione-sensitive and folate-targeted nanoparticles loaded with paclitaxel to enhance oral squamous cell carcinoma therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Proliferation; Drug Liberation; Drug Screening Assays, Antitumor; Folic Acid; Glutathione; Humans; Male; Mice; Mice, Inbred BALB C; Mouth Neoplasms; Nanoparticles; Neoplasms, Experimental; Paclitaxel; Particle Size; Surface Properties; Tumor Cells, Cultured | 2020 |
Paclitaxel Potentiates the Anticancer Effect of Cetuximab by Enhancing Antibody-Dependent Cellular Cytotoxicity on Oral Squamous Cell Carcinoma Cells In Vitro.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Agents, Immunological; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Proliferation; Cetuximab; Drug Synergism; Humans; In Vitro Techniques; Mouth Neoplasms; Paclitaxel; Tumor Cells, Cultured | 2020 |
Obg-like ATPase 1 inhibited oral carcinoma cell metastasis through TGFβ/SMAD2 axis in vitro.
Topics: Adenosine Triphosphatases; Cadherins; Carcinoma; Cell Line, Tumor; Down-Regulation; GTP-Binding Proteins; Humans; Mouth Neoplasms; Neoplasm Metastasis; Paclitaxel; Signal Transduction; Smad2 Protein; Snail Family Transcription Factors; Transforming Growth Factor beta; Up-Regulation | 2020 |
Effectual nanotherapy against oral squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Carriers; Folic Acid; Head and Neck Neoplasms; Mouth Neoplasms; Nanoparticles; Paclitaxel; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution | 2021 |
PTEN Is Activated by the Addition of Cetuximab to Paclitaxel in Oral Squamous Cell Carcinoma.
Topics: Apoptosis; Cell Line, Tumor; Cetuximab; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Paclitaxel; Phosphatidylinositol 3-Kinases; PTEN Phosphohydrolase; Squamous Cell Carcinoma of Head and Neck | 2021 |
Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bacteroidaceae Infections; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Gene Expression; Humans; Male; Mice; Mouth Neoplasms; Neoplasm Metastasis; Paclitaxel; Porphyromonas gingivalis; Receptor, Notch1; Xenograft Model Antitumor Assays | 2017 |
Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Cetuximab; Female; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mouth Neoplasms; Neoplasm Proteins; Paclitaxel; Xenograft Model Antitumor Assays | 2014 |
Combination of Taxol® and dichloroacetate results in synergistically inhibitory effects on Taxol-resistant oral cancer cells under hypoxia.
Topics: Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Dichloroacetic Acid; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Gene Expression; Humans; Mouth Neoplasms; Paclitaxel; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase | 2015 |
Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Docetaxel; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Survival Rate; Taxoids; Young Adult | 2015 |
Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Microtubule-Associated Proteins; Mouth Neoplasms; Paclitaxel | 2015 |
In Vivo Biodistribution and Anti-Tumor Efficacy Evaluation of Doxorubicin and Paclitaxel-Loaded Pluronic Micelles Decorated with c(RGDyK) Peptide.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Resistance, Neoplasm; Humans; Male; Mice, Inbred BALB C; Micelles; Mouth; Mouth Neoplasms; Paclitaxel; Peptides, Cyclic; Poloxamer; Tissue Distribution | 2016 |
Induction chemotherapy before surgery for unresectable head and neck cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Cohort Studies; Disease-Free Survival; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Paclitaxel; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome | 2016 |
Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Carcinoma; Cell Cycle; Cell Proliferation; Cell Survival; Chromatin; DNA Fragmentation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glaucarubin; Humans; KB Cells; Lymphocytes; Membrane Potential, Mitochondrial; Molecular Docking Simulation; Mouth Neoplasms; Paclitaxel; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |
Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bassia scoparia; Carcinoma, Squamous Cell; Caspases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Fruit; Head and Neck Neoplasms; Humans; Male; Methanol; Mice, Inbred C3H; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phytotherapy; Plant Extracts; Plants, Medicinal; Poly(ADP-ribose) Polymerases; Signal Transduction; Solvents; Squamous Cell Carcinoma of Head and Neck; Tumor Burden | 2016 |
[Roles of curcumin combined with paclitaxel on growth inhibition and apoptosis of oral squamous cell carcinoma cell line CAL27 in vitro].
Topics: Apoptosis; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Curcumin; Humans; Mouth Neoplasms; Paclitaxel; Proto-Oncogene Proteins c-bcl-2 | 2016 |
IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Exotoxins; Humans; Interleukin-13; Mice; Mouth Neoplasms; Paclitaxel; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tongue Neoplasms; Transplantation, Heterologous | 2009 |
Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Mouth Neoplasms; Neoplastic Stem Cells; Paclitaxel; Wnt Proteins | 2011 |
Chios mastic gum extracts as a potent antitumor agent that inhibits growth and induces apoptosis of oral cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Cell Line, Tumor; Cell Proliferation; DNA; Drug Screening Assays, Antitumor; Humans; Mastic Resin; Mouth Neoplasms; Paclitaxel; Pistacia; Plant Extracts; Resins, Plant | 2011 |
Poly I:C inhibits cell proliferation and enhances the growth inhibitory effect of paclitaxel in oral sqaumous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Humans; Mouth Neoplasms; Paclitaxel; Poly I-C; Toll-Like Receptor 3 | 2012 |
Antitumor activity of photo-stimulated zinc oxide nanoparticles combined with paclitaxel or cisplatin in HNSCC cell lines.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Catalysis; Cell Line, Tumor; Cisplatin; Drug Synergism; Humans; Metal Nanoparticles; Mouth Neoplasms; Necrosis; Paclitaxel; Ultraviolet Rays; Zinc Oxide | 2012 |
[Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
Topics: Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Maxilla; Maxillary Neoplasms; Mouth; Mouth Neoplasms; Paclitaxel; Teniposide; Tumor Cells, Cultured; Vindesine | 2002 |
Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; ErbB Receptors; Head and Neck Neoplasms; Humans; In Situ Nick-End Labeling; Ligands; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Mouth Neoplasms; Neoplasms; Paclitaxel; Phosphorylation; Propidium; Pyrimidines; Pyrroles; Tongue; Tongue Neoplasms; Tyrosine | 2003 |
The synergistic cytotoxicity of cisplatin and taxol in killing oral squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Fluorouracil; Humans; Inhibitory Concentration 50; Mouth Neoplasms; Paclitaxel; Predictive Value of Tests | 2004 |
Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; ErbB Receptors; Head and Neck Neoplasms; Humans; Immunohistochemistry; Mice; Mice, Nude; Mouth Neoplasms; Paclitaxel; Purines; Receptors, Vascular Endothelial Growth Factor; Signal Transduction | 2004 |
Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Proteins; Cell Division; Docetaxel; Drug Resistance, Neoplasm; Female; G2 Phase; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Microtubules; Middle Aged; Mouth Neoplasms; Neoplasm Proteins; Neoplasms, Squamous Cell; Paclitaxel; Poly-ADP-Ribose Binding Proteins; RNA, Small Interfering; Taxoids; Ubiquitin-Protein Ligases | 2005 |
[Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Multicenter Studies as Topic; Neoadjuvant Therapy; Oropharyngeal Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Survival Analysis | 2006 |
Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of fusaric acid and paclitaxel or carboplatin.
Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Fusaric Acid; Growth Inhibitors; Head and Neck Neoplasms; Humans; Male; Mouth Neoplasms; Nucleic Acid Synthesis Inhibitors; Paclitaxel; Time Factors; Tumor Cells, Cultured | 2006 |
Induction of apoptosis by paclitaxel in human oral carcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Mouth Neoplasms; Paclitaxel; Proto-Oncogene Proteins c-bcl-2 | 2006 |
Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Diffusion; Drug Carriers; Drug Delivery Systems; Humans; Micelles; Mouth Neoplasms; Paclitaxel; Polymers | 2007 |
Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deglutition; Female; Fluoroscopy; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Paclitaxel; Prospective Studies; Tongue; Video Recording | 2007 |
Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Drug Synergism; Genes, Reporter; Humans; Mouth Neoplasms; NF-kappa B; Paclitaxel; Phytic Acid | 2007 |
Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Carcinoma; Cell Cycle; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescent Dyes; Genes, MDR; Growth Inhibitors; Humans; Mice; Mouth Neoplasms; Paclitaxel; Rhodamine 123; Stomach Neoplasms; Tumor Cells, Cultured | 1999 |
[Experimental chemotherapy of xenotransplanted oral squamous epithelial carcinoma: effectiveness of docetaxel (taxotere) in the nude mouse model].
Topics: Aged; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Docetaxel; Humans; Male; Mice; Mice, Nude; Mouth Mucosa; Mouth Neoplasms; Neoplasm Transplantation; Paclitaxel; Taxoids; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |
Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Endothelial Growth Factors; Female; Humans; Lymphokines; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; RNA, Messenger; Thalidomide; Transplantation, Heterologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
[A new method for study of the effect of drugs on cancer cells--31PNMR with perfused cell system].
Topics: Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Humans; Magnetic Resonance Spectroscopy; Mouth Neoplasms; Paclitaxel; Phosphorus Isotopes; Tumor Cells, Cultured; Vincristine | 1998 |